Referencias
Anxiety & Depression Association of America. (n.d.). Generalized anxiety Disorder (GAD): Anxiety and Depression Association of America, ADAA. Retrieved May 11, 2021, from https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad
Bushnell, G. A., Gerhard, T., Crystal, S., & Olfson, M. (2020). Benzodiazepine Treatment and Fracture Risk in Young Persons with Anxiety Disorders. Pediatrics, 146(1). https://doi.org/10.1542/peds.2019-3478
Canino, G., Shrout, P. E., NeMoyer, A., Vila, D., Santiago, K. M., Garcia, P., … Alegria, M. (2019). A comparison of the prevalence of psychiatric disorders in Puerto Rico with the United States and the Puerto Rican population of the United States. Social Psychiatry and Psychiatric Epidemiology, 54(3), 369–378. https://doi.org/10.1007/s00127-019-01653-6
Crocq, M. (2015). A history of ANXIETY: FROM Hippocrates to DSM. Anxiety, 17(3), 319-325. doi:10.31887/dcns.2015.17.3/macrocq
Holland, J., Hatcher, W., & Meares, W. (2018). Understanding the Implementation of Telemental Health in Rural Mississippi. Journal of Health and Human Services Administration, 41(1), 52–86.
How stress affects your body and behavior. (2019, April 04). Retrieved May 11, 2021, from https://www.mayoclinic.org/healthy-lifestyle/stress-management/in-depth/stress-symptoms/art-20050987
Keers, R., Coleman, J. R. I., Lester, K. J., Roberts, S., Breen, G., Thastum, M., … Eley, T. C. (2016). A Genome-Wide Test of the Differential Susceptibility Hypothesis Reveals a Genetic Predictor of Differential Response to Psychological Treatments for Child Anxiety Disorders. Psychotherapy and Psychosomatics, 85(3), 146–158. https://doi.org/10.1159/000444023
Kishimoto, T., Krieger, T., Berger, T., Qian, M., Chen, H., & Yang, Y. (2016). Internet-Based Cognitive Behavioral Therapy for Social Anxiety with and without Guidance Compared to a Wait List in China: A Propensity Score Study. Psychotherapy and Psychosomatics, 85(5), 317–319. https://doi.org/10.1159/000446584
Mayo Clinic. (2018, May 04). Anxiety disorders. Retrieved May 11, 2021, from https://www.mayoclinic.org/diseases-conditions/anxiety/symptoms-causes/syc-20350961
Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., … Benedetti, F. (2020). Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, Behavior, and Immunity, 89, 594–600. https://doi.org/10.1016/j.bbi.2020.07.037
Nordahl, H. M., Vogel, P. A., Morken, G., Stiles, T. C., Sandvik, P., & Wells, A. (2016). Paroxetine, Cognitive Therapy or Their Combination in the Treatment of Social Anxiety Disorder with and without Avoidant Personality Disorder: A Randomized Clinical Trial. Psychotherapy and Psychosomatics, 85(6), 346–356. https://doi.org/10.1159/000447013
Scaramutti, C., Salas-Wright, C. P., Vos, S. R., & Schwartz, S. J. (2019). The Mental Health Impact of Hurricane Maria on Puerto Ricans in Puerto Rico and Florida. Disaster Medicine and Public Health Preparedness, 13(1), 24–27. https://doi.org/10.1017/dmp.2018.151
Shinfuku, M., Kishimoto, T., Uchida, H., Suzuki, T., Mimura, M., & Kikuchi, T. (2019). Effectiveness and safety of long-term benzodiazepine use in anxiety disorders. International Clinical Psychopharmacology, 34(5), 211–221. https://doi.org/10.1097/yic.0000000000000276
Yoshinaga, N., Matsuki, S., Niitsu, T., Sato, Y., Tanaka, M., Ibuki, H., … Shimizu, E. (2016). Cognitive Behavioral Therapy for Patients with Social Anxiety Disorder Who Remain Symptomatic following Antidepressant Treatment: A Randomized, Assessor-Blinded, Controlled Trial. Psychotherapy and Psychosomatics, 85(4), 208–217. https://doi.org/10.1159/000444221
Enlace del podcast: https://anchor.fm/xavier-aviles-hernandez/episodes/Neurobiology-Podcast-e10lqaq